A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women

Sexually Transmitted Infections

Volumn 76, Issue 2, 2000, Pages 126-130

  Van Damme, Lut ^a   Profy, Al ^c   Laga, Marie ^a   Kitchen, Val ^b   Wright, Ann ^b   Depraetere, Katrien ^a   Rosenstein, Isobel ^b   Vandersmissen, Veerle ^a   Poulter, Len ^b   McKinlay, Margo ^c   Van Dyck, Eddy ^a   Weber, Jonathan ^b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b ST MARY S HOSPITAL   (United Kingdom)

^c Procept Inc   (United States)

Author keywords

Microbicide; PRO 2000; Toxicity; Women

Indexed keywords

ANTIINFECTIVE AGENT; PLACEBO; PRO 2000; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; FEMALE; GEL; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUALLY TRANSMITTED DISEASE; TOXICITY TESTING; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BELGIUM; COHORT STUDIES; DOUBLE-BLIND METHOD; EPITHELIAL CELLS; FEMALE; GELS; GREAT BRITAIN; HIV INFECTIONS; HUMANS; MIDDLE AGED; NAPHTHALENESULFONATES; PATIENT SATISFACTION; POLYMERS; SEXUAL ABSTINENCE; TREATMENT OUTCOME; VAGINAL DISEASES;

EID: 0034059527     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.2.126     Document Type: Article

References (18)

1. 1 Elias CJ, Heise LL. Challenges for the development of female-controlled vaginal microbicides. AIDS 1994;8: 1-9.
2. 2 Global Programme on AIDS, World Health Organisation. Report on a meeting on the development of vaginal microbicides for the prevention of heterosexual transmission of HIV. Geneva: GPAWHO 1993. (Document WHO GPA RID/CRD '94.1:11-13 November 1993.)
3. 3 Hicks DR, Martin LS, Getchell JP, et al. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet 1985;2:1422 -3.
4. 4 Harrison C, Chantler E. The effect of nonoxynol-9 and chlorhexidine on HIV and sperm in vitro. Int J STD AIDS 1998;9:92-7.
5. 5 Roddy RE, Zekeng L, Ryan KA, et al. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998;339:504-10.
6. 6 Stafford MK, Ward H, Flannagan A, et al. Safety study of nonoxynol-9 as a vaginal mircobicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:327-31.
7. 7 Rosenstein IJ, Stafford MK, Kitchen VS, et al. Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. J Infect Dis 1998;177:1386-90.
8. 8 Rosenstein IJ, Fontaine EA, Morgan D, et al. Relationship between hydrogen peroxide-producing strains of lactobacilli and vaginosis-associated bacterial species in pregnant women. Eur J Clin Microbiol Infect Dis 1997;16:517-22.
9. 9 Balzarini J, Naesens L, Verbeken E, et al. Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent. AIDS 1998;12:1129-38.
10. 10 Ongradi J, Ceccherini-Nelli L, Pistello M, et al. Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications. AIDS Res Hum Retroviruses 1990;6:1433-6.
11. 11 Klebanoff SJ, Coombs RW. Virucidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 1991;174:289-92.
12. 12 Sonderfan AJ, Chancellor T, Buckheit Jr RW, et al. Safety and in vitro efficacy of a topical microbicide gel for the prevention of HIV-1 transmission. 4th Conference on Retroviruses and Opportunistic Infections, Washington DC, January 1997 (Abstract 522).
13. 13 Profy AT, Sonderfan AJ, Bernstein DI, et al. PRO 2000 gel, a potential topical microbicide for HIV prevention, can block infection by other sexually transmitted disease pathogens. 12th World AIDS Conference, Geneva, June 1998 (Abstract 33146).
14. 14 Bourne N, Bernstein DI, Ireland J, et al. The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. J Infect Dis (in press).
15. 15 Sonderfan AJ, Chancellor T, Buckheit RW Jr, et al. Safety and in vitro efficacy of a topical microbicide gel for the prevention of HIV-1 transmission. 4th Conference on Retroviruses and Opportunistic Infections, Washington DC, 22-26 January 1997.
16. 16 WHO WHO/GPA/RID/CRD. Manual for the standardization of colposcopy for the evaluation of vaginally administered products. Geneva: World Health Organisation, 1995.
17. 17 Hillier SL. Recolonisation of the vagina with an exogenous strain of Lactobacillus crispatus. BV 98 Aspen Colorado, 17-19 September 1998.
18. 18 Van Damme L, Niruthisard S, Atisook R, et al. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS 1998;12:433-7.